The share price of Biogen Inc. (NASDAQ:BIIB) tumbled as much as 8 percent, to $395, Friday after sales of the …
Biogen Inc (NASDAQ:BIIB) stock had a fantastic start to September with a 15% rally. But in the past few days of trading, it gave back about one-third of it. Source: Biogen via YouTube Clearly, this is a momentum stock, so it will never give …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
There are times when a negative piece of news in the BioPharma sector can actually help rival companies. Biogen Inc. (NASDAQ: BIIB) is a stock that has been battered of late, and it is a key company in the treatment for multiple …
12/22 $CS SEES WRITE-DOWN OF ABOUT CHF 2.3B ON TAX REFORM once worked at CSFB i t.. 12/22 BRIEF-Credit Suisse Says it Expects Write-Down Of about Chf 2.3 bln In Q4 201.. 12/22 Credit Suisse : US Tax Cuts and Jobs Act …
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. Biogen (NASDAQ: BIIB) announced that its Board of Directors authorized a program to repurchase up to $5 billion of the …
Yesterday’s rumored M&A interest in Biogen Inc (NASDAQ:BIIB) spiked the stock 10% in a single day. Now that the euphoria has died down, let’s examine what a realistic takeover number might be. With both Merck and Allergan …
Additionally, Biogen expects that starting on January 12, 2017, common stock of Biogen will trade on the NASDAQ Global Select Market in two markets: "regular-way" under the symbol "BIIB" and in the "ex-distribution" market under the …
AEZS closed Monday's trading at $2.06, down 1.90%. In after-hours, the stock was up 4.37% to $2.15. Biogen (BIIB) and Alkermes plc (ALKS) have entered into a global license and collaboration agreement to develop and commercialize …
Biogen Inc. (BIIB) secured a legal victory when its intellectual property ... The positive verdict announcement spiked Biogen stock price by around 3.6% on Tuesday, as the stock touched an intraday high of $284.71 per share. In January, …